Proving the Business Case for the Internet of Things

Oracle collects data from sensors and wearables for clinical trials

Steve Rogerson
April 17, 2018



Oracle Health Sciences has launched an mhealth connector cloud service that lets clinical study teams remotely collect e-source data from patient sensors, wearables and apps for use in clinical trials.
 
The rise of mobile health technologies including mobile sensors, patient engagement apps and telemedicine is reshaping how drugs are developed by improving the efficiency of clinical trials. Oracle's mhealth service should make it easier to connect existing clinical systems with a wide variety of e-sources, enabling therapeutic teams to obtain more accurate and rich patient data, improve adherence to study protocols, better understand the safety and efficacy of trial drugs, and improve patient centricity with remote patient monitoring.
 
"We are thrilled to announce our new mhealth connector cloud service as it holds great promise in speeding clinical trials and bringing more drugs to market faster," said Steve Rosenberg, general manager of Oracle Health Sciences. “Being able to take what used to be patient-recorded data and outcomes via paper forms and site visits can now be done via mobile health sensors and wearables that have the potential to shorten trial times and reduce costs, while allowing sick patients to remain in the comfort of their homes versus travelling to and from trial sites. To improve patient enrolment in clinical trials, study teams must put the patient at the centre of everything they do, and emerging technologies such as wearables and sensors hold the key.”
 
The service supports a number of integration approaches and Oracle is exploring integration efforts with a wide ecosystem of mobile health companies such as Validic, MC10 and CMT as well as integrators and developers such as Accenture and Possible Mobile.
 
"Accenture is committed to advancing new approaches in clinical research through collaborations with our clients and Oracle Health Sciences," said Kevin Julian, senior managing director at Accenture. “Together we're developing ways to transform clinical trial processes by creatively applying digital capabilities. We believe mhealth will allow faster and easier integration of a wide range of devices and sensors in real time, streamlining data collection and enhancing the patient experience."
 
CMT’s CleverCap product family blends technology with the connected patient to help track and improve medication dosing habits in clinical trials.
 
“Our collaboration with Oracle Health Sciences enables a seamless real-time display of dosing patterns data into the e-clinical systems that clinical trial sites and clinical teams utilise, alongside other essential clinical trial data," said Moses Zonana, CEO of CMT.
 
MC10’s business is focused on a gathering complex physiological data direct from wearable sensors worn by research subjects.
 
“We're excited to collaborate with Oracle Health Sciences, and seamlessly flow our data direct into Oracle's clinical trial applications, and be part of the new paradigm of digital clinical trials," said Scott Pomerantz, CEO and president of MC10.
 
Jay Graves, CTO of Possible Mobile, added: "Using the Oracle mhealth connector cloud service, we were able to easily transfer patient data from our Apple ResearchKit apps to the clinical trial cloud application. The integration process was straightforward and painless."
 
Validic is working with Oracle in a collaboration to merge vital data sources and novel endpoints to enable patient centricity and efficiency in clinical trials.
 
"Designing a clinical trial to better engage participants requires utilisation of new data sources," said Drew Schiller, CEO of Validic. “By automating the passive collection of data via digital health devices and apps, researchers are able to access more accurate, diverse and objective data, enabling sponsors to better manage participant engagement and programme adherence.”